Business as Usual for Endologix as it Considers $98 Million Buyout

More good news from Endologix, the Irvine, CA-based company mulling over a $98 million buyout bid from hedge fund Elliott Associates. This week, the company’s IntuiTrak Delivery System was approved by the FDA. The System will be used to deliver and deploy the company’s stent graft, for the endovascular...

NxStage Medical Signs Long-Term Supply Agreement with Renal Advantage

NxStage Medical has signed a long-term product supply agreement with Renal Advantage (RAI), the fourth largest provider of dialysis services in the U.S. Under the terms of the agreement, NxStage will supply the Streamline airless blood tubing set, MasterGuard and other products to RAI’s dialysis center...

CoreValve Prevails in German Patent Infringement Lawsuit with Edwards

A German Federal Court has found that CoreValve’s ReValving system (for transcatheter aortic valve replacement) does not infringe any of the claims of the Andersen patent held by Edwards Lifesciences. That patent relates to the implantation of a valve prosthesis using a catheter. Edwards, which offers the...

Elliott Associates Submits $98 Million Lowball Bid for Endologix

The New York-based hedge fund, Elliott Associates, has offered to buy all of the outstanding shares of Endologix for $98 million or $2.25 per share. The unsolicited proposal came yesterday. Endologix stock, which had hovering at or below the $2-range earlier this week, jumped on the news. Elliott’s offer...

Treating Disc Degeneration from the Inside Out: New Preclinical Data from ISTO Technologies

ISTO Technologies announced positive preclinical data for its spinal disc repair therapy, NuQu. In collaboration with the University of California San Francisco (UCSF), ISTO is investigating potential applications of the company’s core cell-based platform technology. ISTO’s orthobiologic products are...

Kinetic Concepts Gets FDA Clearance For Tissue Matrix

Kinetic Concepts (KCI) has received FDA 510(k) clearance for its LifeCell Tissue Matrix. The matrix is used to treat chronic, trauma, surgical and other acute wounds. The product utilizes the company’s Strattice technology, a sterile reconstructive tissue matrix that supports tissue...

Medtech Insight: In3 East

Meet the most important people in medical technology at In3 East, the largest East Coast strategic partnership and investment meeting for senior-level medical technology executives. Hundreds of venture capital companies and medical technology companies will gather to learn about the latest innovations and...

NeoChord Receives Cash Infusion from Clarian Health Ventures

An infusion of capital will help NeoChord go the distance. Previously, the company had raised $1.76 million from angel investors in a convertible debt offering. Clarian Health Ventures, an Indiana-based fund, made the investment. The company is both an investor and a clinical partner, said NeoChord’s CEO,...